Cited by 99Cardiovascular Health and Disease PreventionBlood Pressure and Hypertension StudiesHemodynamic Monitoring and Therapy

Meta‐analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index

Open access
Manisty, Charlotte H., Hughes, Alun D.·2013·British Journal of Clinical Pharmacology

Abstract

AIMS Brachial systolic blood pressure (bSBP) exceeds aortic pressure by a variable amount, and estimated central systolic blood pressure (cSBP) may be a better indicator of cardiovascular risk than bSBP. We undertook a systematic review and meta‐analysis to compare the effect of single and multiple antihypertensive agents on bSBP, cSBP and augmentation index (AIx). Methods A random effects meta‐analysis was performed on 24 randomized controlled trials of antihypertensives with measurements of bSBP, cSBP and/or AIx. Separate analyses were performed for drug comparisons with or without placebo, and drug combinations. Results In the placebo vs. drug meta‐analysis, antihypertensive therapy reduced bSBP more than cSBP and there was no statistically significant evidence of heterogeneity by drug class, although the number of individual studies was small. In placebo‐adjusted drug vs. drug comparison, treatment with β‐blockers, omapatrilat and thiazide diuretics lowered cSBP significantly less than bSBP (i.e. central to brachial amplification decreased), whereas other monotherapies lowered cSBP and bSBP to similar extents. Sample sizes were too small and effect estimates insufficiently precise to allow firm conclusions to be made regarding comparisons between individual drug classes. Antihypertensive combinations that included β‐blockers decreased central to brachial amplification. β‐Blockers increased AIx, whereas all other antihypertensive agents reduced AIx to similar extents. CONCLUSIONS A reduction in central to brachial amplification by some classes of antihypertensive drug will result in lesser reductions in cSBP despite achievement of target bSBP. This effect could contribute to differences in outcomes in randomized clinical trials when β‐blocker‐ and/or diuretic‐based antihypertensive therapy are compared with other regimens.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.2012.04342.x

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. National Institute for Clincial Excellence and British Hypertension Society. NICE/BHS Hypertension Guideline Review. 28-6-2006.

Cited by

Sorted by citations

Authors
Manisty, C. H., & Hughes, A. D.
Affiliations
Imperial College Healthcare NHS Trust (GB)
Corresponding author
Hughes, Alun D.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2012-12-14
Volume
75
Issue
1
Pages
79-92
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W1494527914
Cited by
99
References
85
Citations by year
2026: 1 · 2025: 7 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 7 · 2019: 10 · 2018: 9 · 2017: 17 · 2016: 10 · 2015: 14 · 2014: 7 · 2013: 2 · 2012: 1
FWCI
4.94
Type
journal article
Language
en
Open access
Locations
  • British Journal of Clinical Pharmacology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Keywords
antihypertensive drugs, central systolic blood pressure, brachial systolic blood pressure, augmentation index, beta-blockers, thiazide diuretics, omapatrilat, combination antihypertensive therapy, cardiovascular risk, blood pressure reduction
MeSH terms
Antihypertensive Agents, Aorta, Blood Pressure, Brachial Artery, Humans, Systole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review